Categories: Top Stories

US pharma giant is unhappy with Germany; CEO calls planned healthcare reform ‘terrible’

US drug maker Eli Lilly is cutting its investment in a German factory by half. This decision follows new healthcare cost-cutting laws in Germany. The company CEO called the reforms a bad signal for the industry. This move impacts Germany’s industrial plans. The factory will now operate at reduced capacity with fewer jobs. Other companies are also reconsidering local investments.

The News Vista

Share
Published by
The News Vista

Recent Posts

Matt: Toni on Verge

Toni Schneider, Automattic’s founding CEO, board member, and now CEO of Bluesky, has a great…

1 hour ago

Minnesota solar farms turn into wildflower havens, invites bee and butterflies

Minnesota solar farms seeded with native plants tripled insect abundance. Native bees increased twentyfold, and…

2 hours ago

Pradeep Rawat’s son Vikramaditya recalls actor’s battle with blood cancer at prayer meet

Family, friends and colleagues gathered in Mumbai to remember veteran actor Pradeep Rawat, as his…

2 hours ago

Iltija faces FIR, questioning over ‘assault’ on cop, accuses police of manhandling; Omar calls it ‘fixed match’

Omar Abdullah, J&K chief minister, labeled the Iltija Mufti incident a contrived event, alleging that…

2 hours ago

Police put up posters of Lashkar commander across J&K, declare Rs 15L reward

Authorities are on the hunt for Lashkar commander Mohammad Lateef Bhat throughout Kashmir and Jammu,…

2 hours ago